About 40% of the cancer burden in high income countries can be explained by known risk factors, although international differences in incidence point to other unknown causes. Several established carcinogens leave specific mutation patterns in the cancer genome, ie mutational signatures. This suggests that sequencing large numbers of tumour samples from different populations may be a useful strategy to identify novel causes of cancer.